VRDN Archived Articles
Viridian Therapeutics (NASDAQ:VRDN) - Developing Innovative Therapies for Serious Diseases
Published on November 17, 2024
Viridian Therapeutics: Advancing Innovative Therapies for Thyroid Eye Disease and Autoimmune Disorders
Published on September 24, 2024